all psychiatric disorders in adolescence
Conditions
Interventions
Group 1: App-assisted psychotherapy will be assessed in a quasi-experimental one-group pre-post design in a multicenter study. Both patients and psychotherapists will be interviewed about the feasibil
Sponsors
Universitätsklinikums für Kinder- und Jugendpsychiatrie und Psychotherapie, Evangelisches Klinikum Bethel
Eligibility
Sex/Gender
All
Age
12 Years to 21 Years
Inclusion criteria
Inclusion criteria: Patients: outpatient treatment in one of the study centers (Bielefeld, Cologne, Frankfurt, Mannheim); mental illness (with a focus on depression, social phobia or other anxiety disorders); availability of a terminal device with Android operating system. Psychotherapists: Staff of the outpatient clinic of a participating study center (Bielefeld, Cologne, Frankfurt, Mannheim); consent to participate in the study.
Exclusion criteria
Exclusion criteria: No consent for study participation; Not a patient or employee of a participating study center during the survey period; For patients: no availability of a terminal device with Android operating system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perceived app quality by patient and therapist (surveyed by the uMARS (user version of the Mobile Application Rating Scale) at T2P & T2T) and satisfaction with the app by patient and psychotherapist (surveyed by the short version of the ZUF-8 (questionnaire for measuring patient:s satisfaction) and a subscale of the uMARS at T2P and T2T and by psychotherapist with five self-generated questions in the context of a qualitative interview). | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of adherence (of patient in external report by psychotherapist by rating of reliability, commitment, number of missed therapy sessions and evaluation of utilization data of patient and therapist) & therapeutic alliance from patient and therapist (measured by Working Alliance Inventory -short revised; WAI-SR at T2P) & Patient Self-Efficacy (measured by General Self-Efficacy Expectancy Scale; SWE at T1P and T2P) & Symptom Reduction (measured by Pediatric Symptom Checklist- Youth Version; PSC-Y at T1P and T2P) & Quality of Life (measured by KIDSCREEN-10 at T1P and T2P). | — |
Countries
Germany
Contacts
Public ContactMichael Siniatchkin
Universitätsklinikums für Kinder- und Jugendpsychiatrie und Psychotherapie, Evangelisches Klinikum Bethel
Outcome results
None listed